touchPODCAST

Personalized treatment of RET-altered thyroid cancers


Listen Later

touchEXPERT OPINIONS for touchENDOCRINOLOGY

Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers

The experts

  • Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA
  • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical educational grant from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.


    For further information visit our website: https://touchendocrinologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies//?_ga=2.65262702.1175448380.1654530922-407959475.1653925964

    ...more
    View all episodesView all episodes
    Download on the App Store

    touchPODCASTBy touchpodcast